SCHEMBL7523868

SCHEMBL7523868

CC(C)Cc1ccc(NC(=O)NNC2=CC(=O)OC2)cc1Cl

nearest known ligand 0.38

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.38
P2RX3 P56373 9/20 0.37
RAB9A P51151 3/20 0.36
NPC1 O15118 2/20 0.36
ALDH1A1 P00352 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MAPT P10636 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
TP53 P04637 1/20 0.36
KDM4E B2RXH2 1/20 0.35
TSHR P16473 1/20 0.35
FPR2 P25090 1/20 0.35
EPHX1 P07099 1/20 0.35
EPHX2 P34913 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7523871 0.82 LMNA (0.35) LMNARAB9ANPC1ALDH1A1MAPT
SCHEMBL7518027 0.79 RAB9A (0.45) LMNARAB9ANPC1SMN1; SMN2MAPT
SCHEMBL27524607 0.76 RAB9A (0.44) LMNARAB9ANPC1SMN1; SMN2MAPT
SCHEMBL7515770 0.73 LMNA (0.49) LMNARAB9ANPC1ALDH1A1SMN1; SMN2
SCHEMBL7554903 0.73 RAB9A (0.42) LMNAP2RX3RAB9ANPC1ALDH1A1
SCHEMBL7525013 0.72 EPHX1 (0.61) LMNARAB9ANPC1ALDH1A1SMN1; SMN2
SCHEMBL7522213 0.72 RAB9A (0.45) LMNARAB9ANPC1ALDH1A1SMN1; SMN2
SCHEMBL7515054 0.72 RAB9A (0.56) RAB9ANPC1SMN1; SMN2MAPTMEN1
SCHEMBL7524987 0.71 PPIA (0.46) LMNARAB9ANPC1ALDH1A1SMN1; SMN2
SCHEMBL7517906 0.70 KMT2A (0.38) RAB9ANPC1ALDH1A1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1173420-A2 HETEROCYCLIC COMPOUNDS HAVING ANTITUMOR ACTIVITY Novuspharma S.p.A. (IT) 2002-01-23 EP disclosed
WO-2000053581-A2 HETEROCYCLIC COMPOUNDS HAVING ANTITUMOR ACTIVITY NOVUSPHARMA S.P.A. (IT) 2000-09-14 WO disclosed